The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with ...

LifeMD fell 25% YTD, with nearly 1x 2025 sales, improved Q3 results, and a WorkSimpli divestiture worth up to $50M. See why ...

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

Starting in January, public workers and retirees enrolled in Group Insurance Commission plans will need to participate in a new program to maintain coverage for GLP-1 prescriptions as ...

Plus, studies show that a high-protein diet can help with losing fat and gaining muscle at the same time. Research shows that, while in a calorie deficit, consuming more protein than you normally ...

You deserve more than another diet. That’s why VitaLife is offering a unique approach to weight loss built on science and ...

Remedy Meds is an online consumer health and pharmacy platform that provides access to compounded glucagon-like peptide-one ...

Telemedicine is revolutionizing healthcare access, supported by regulatory measures, such as the 1135 waiver and the Coronavirus Preparedness Act, which expanded Medicare coverage for telehealth ...

Q3 2025 Earnings Call Transcript November 17, 2025 LifeMD, Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, ...

Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million.Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30% ...

Q3 2025 Earnings Call November 17, 2025 4:30 PM ESTCompany ParticipantsJustin Schreiber - Chairman & CEOMarc Benathen - ...

Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million.Telehealth revenue grew 18% to $47.3 ...